
Maharashtra FDA halts Cadila godowns over Aciloc name mix-up
The story in brief
Maharashtra FDA suspended three Cadila godowns in Pune, Nagpur, and Thane after finding drugs with similar names to Aciloc were sold with different active ingredients. The agency prohibited affected drug sales, impacting residents and pharmacies, as some wholesalers received famotidine versions instead of ranitidine ones. The company faces a 21-day deadline to respond.